Skip to content
buyModerate cluster of 2

Michael Joseph Golembiewski bought $100k of SEEL

Chief Financial Officer at SEELOS THERAPEUTICS, INC.. 83,000 shares at an average of $1.21, traded Nov 30, 2023, filed Dec 1, 2023.

Conviction score
50
Value
$100k
83,000 shares
Holdings after
86,450
+2406% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    CFO
    +22
  • Trade size
    $100k at market
    +10
  • Relative to holdings
    Holdings up 2406%
    +10
  • Price context
    No price history yet
    0
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001104659-23-122841, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 30, 2023POpen-market purchase
Common Stock
+83,000$1.21$100k86,450Dec 1, 2023

Related signals

Other insiders at SEELOS THERAPEUTICS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
43Moderate
SEELbuy 2
SEELOS THERAPEUTICS, INC.
Raj Mehra
See Remarks
$100k
75,757 shares
+69%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Michael Joseph Golembiewski bought $100k of SEEL | InsiderTell